Company Overview

Embrex, Inc., a biotechnology company, engages in the development, sale, and lease of biological and mechanical products for the poultry industry in the United States and internationally. It offers the Inovoject system, a proprietary, automated in-the-egg injection system, which can process 20,000 to 70,000 eggs per hour and eliminates the need for manual, post-hatch injection of certain vaccines. The company also markets the Egg Remover system to remove infertile and early-dead eggs from incubator trays prior to transfer to the hatching incubator or inoculation through the Inovoject system; and the Vaccine Saver option for the Inovoject system, which identifies infertile and early-dead eggs...

Embrex, Inc., a biotechnology company, engages in the development, sale, and lease of biological and mechanical products for the poultry industry in the United States and internationally. It offers the Inovoject system, a proprietary, automated in-the-egg injection system, which can process 20,000 to 70,000 eggs per hour and eliminates the need for manual, post-hatch injection of certain vaccines. The company also markets the Egg Remover system to remove infertile and early-dead eggs from incubator trays prior to transfer to the hatching incubator or inoculation through the Inovoject system; and the Vaccine Saver option for the Inovoject system, which identifies infertile and early-dead eggs, and selectively prevents vaccination of these eggs. In addition, it offers vaccines based on an antigen-antibody complex technology, which include Bursaplex for protection against avian infectious bursal disease and Newplex for protection against Newcastle disease. Further, Embrex develops various other proprietary mechanical and biological products for the poultry industry, including Inovocox, for protection against coccidiosis. Additionally, it provides contract research and development services. The company primarily markets its products and services to commercial poultry producers and human flu vaccine producers. Embrex Inc. was incorporated in 1985 and is headquartered in Durham, North Carolina. As of January 19, 2007, Embrex, Inc. operates as a subsidiary of Pfizer Animal Health.

Key Executives for Embrex Inc.

Similar Private Companies By Industry

Recent Private Companies Transactions